Finance

Beta
Lists
002550:SHE
Changzhou Qianhong Biopharma Co Ltd
CN¥5.92
+2.42%
(+0.14) 1D
Jun 23, 3:04:30 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002550...
Open
CN¥5.76
High
CN¥6.04
Low
CN¥5.73
Mkt. cap
7.49B
Avg. vol.
11.56M
Volume
21.25M
Dividend
2.53%
Quarterly dividend
CN¥0.04
Ex-dividend date
May 29, 2026
P/E ratio
22.93
52-wk high
CN¥12.75
52-wk low
CN¥5.69
EPS
CN¥0.26
Shares outstanding
1.28B
No. of employees
1K
Open
CN¥5.76
High
CN¥6.04
Low
CN¥5.73
Mkt. cap
7.49B
Avg. vol.
11.56M
Volume
21.25M
Dividend
2.53%
Quarterly dividend
CN¥0.04
Ex-dividend date
May 29, 2026
P/E ratio
22.93
52-wk high
CN¥12.75
52-wk low
CN¥5.69
EPS
CN¥0.26
Shares outstanding
1.28B
No. of employees
1K
News stories
From sources across the web
About Changzhou Qianhong Biopharma Co Ltd
CEO-
Employees1.04K
Founded1971
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
410.89M
353.24M
356.26M
358.08M
Cost of goods sold
170.87M
137.30M
151.56M
139.36M
Cost of revenue
170.87M
137.30M
151.56M
139.36M
Research and development expenses
27.45M
26.02M
40.80M
20.49M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
109.12M
109.16M
144.09M
92.04M
Operating expense
200.49M
12.39M
308.71M
112.00M
Total operating expenses
371.36M
149.69M
460.27M
251.36M
Operating income
39.53M
203.55M
-104.01M
106.72M
Other non operating income
57.10M
-63.16M
121.49M
-10.32M
EBT including unusual items
106.06M
144.70M
12.38M
102.80M
EBT excluding unusual items
100.02M
148.88M
8.02M
99.47M
Income tax expense
14.09M
26.15M
7.26M
18.30M
Effective tax rate
13.29%
18.07%
58.64%
17.80%
Other operating expenses
6.75M
-3.03M
8.75M
-756.78K
Net income
97.08M
125.18M
15.57M
85.06M
Net profit margin
23.63%
35.44%
4.37%
23.75%
Earnings per share
-
-
-
-
Interest and investment income
5.61M
6.52M
4.69M
3.08M
Interest expense
-
-254.74K
-22.87K
-
Net interest expenses
5.61M
6.26M
4.66M
3.08M
Depreciation and amortization charges
-
-
-
-
EBITDA
54.72M
219.70M
-87.82M
122.91M
Gain or loss from assets sale
-
-
-14.36K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more